The EU Commission gives conditional clearance to an acquisition in the production of generic medicines (Teva / Barr Pharmaceuticals)

Mergers: main developments between 1 September and 31 December 2008* On 19 December the Commission gave conditional approval to the proposed acquisition of Barr Pharmaceuticals of the US by Teva Pharmaceutical Industries of Israel. Both companies produce generic medicines. To remedy the Commission’s competition concerns in the field of cancer drugs and prescription vitamin products on a number of national markets,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • JG Associates (Brussels)
  • DG COMP (Brussels)

Quotation

John Gatti, Mary Loughran, The EU Commission gives conditional clearance to an acquisition in the production of generic medicines (Teva / Barr Pharmaceuticals), 19 December 2008, e-Competitions December 2008, Art. N° 37675

Visites 368

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues